6 insiders reported 22 Form 4 transactions for Nuo Therapeutics, Inc. (AURX) over the past 18 months (most recent 2026-06-05). Recent activity: JORDEN DAVID EMERSON (CEO/CFO) Buy 13,245 shares, JORDEN DAVID EMERSON (CEO/CFO) Buy 125,000 shares, JORDEN DAVID EMERSON (CEO/CFO) Sell 25,381 shares, WINZER C ERIC (Director) Buy 68,750 shares, WINZER C ERIC (Director) Sell 13,750 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | JORDEN DAVID EMERSON | CEO/CFO | Buy | 13,245 | $14,506 |
| 2026-01-05 | JORDEN DAVID EMERSON | CEO/CFO | Buy | 125,000 | $50,000 |
| 2026-01-05 | JORDEN DAVID EMERSON | CEO/CFO | Sell | 25,381 | $50,001 |
| 2025-12-22 | WINZER C ERIC | Director | Buy | 68,750 | $27,500 |
| 2025-12-22 | WINZER C ERIC | Director | Sell | 13,750 | $27,500 |
| 2025-12-11 | Mintz Paul | Director | Buy | 50,000 | $20,000 |
| 2025-12-11 | Mintz Paul | Director | Sell | 9,091 | $20,000 |
| 2025-12-11 | Mintz Paul | Director | Buy | 50,000 | $20,000 |
| 2025-12-11 | Mintz Paul | Director | Sell | 9,091 | $20,000 |
| 2025-12-03 | JORDEN DAVID EMERSON | CEO/CFO | Sell | 200,000 | $300,000 |
| 2025-08-04 | JORDEN DAVID EMERSON | CEO/CFO | Buy | 100,000 | $40,000 |
| 2025-08-04 | JORDEN DAVID EMERSON | CEO/CFO | Buy | 92,710 | $37,084 |
| 2025-08-04 | JORDEN DAVID EMERSON | CEO/CFO | Sell | 21,313 | $37,085 |
| 2025-08-04 | WINZER C ERIC | Director | Buy | 120,313 | $48,125 |
| 2025-08-04 | WINZER C ERIC | Director | Sell | 27,659 | $48,127 |
| 2025-08-04 | Mintz Paul | Director | Buy | 87,500 | $35,000 |
| 2025-08-04 | Mintz Paul | Director | Sell | 20,115 | $35,000 |
| 2025-08-04 | CLAUSEN PETER | CSO/COO | Buy | 183,853 | $73,541 |
| 2025-08-04 | WINZER C ERIC | Director | Buy | 120,313 | $48,125 |
| 2025-08-04 | WINZER C ERIC | Director | Sell | 27,659 | $48,127 |
| 2025-08-01 | SHEEDY CHARLES E | Insider | Buy | 133,333 | $200,000 |
| 2025-08-01 | Pittman Scott M. | Director | Buy | 3,946 | $5,919 |
Source: SEC Form 4 filings · as of 2026-06-05